Evidence map›Paper›PMID 41980093›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo.

Elena V Romero, Abigail E Clyde, Elena E Giorgi, Dylan H Westfall, Walker Azam, Megan L Taylor, Marina Caskey, Alison F Feder, Lillian B Cohn

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Elena V Romero *Department of Genome Sciences, University of Washington, Seattle, WA 98105.ORCID 0000-0002-2631-3289
Abigail E Clyde *Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.ORCID 0000-0002-7256-1259
Elena E GiorgiVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.ORCID 0000-0003-2968-1033
Dylan H WestfallVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.ORCID 0000-0002-2434-8525
Walker AzamVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.ORCID 0009-0002-2613-3576
Megan L TaylorDepartment of Genome Sciences, University of Washington, Seattle, WA 98105.ORCID 0009-0002-2511-1498
Marina CaskeyLaboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.
Alison F Feder *Department of Genome Sciences, University of Washington, Seattle, WA 98105.ORCID 0000-0003-2915-089X
Lillian B Cohn *Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.ORCID 0000-0002-3485-8692

Funding

Defining the mechanisms of HIV resistance to bNAbs in humansU01AI169385 · NIAID · ROCKEFELLER UNIVERSITY · PI Marina Caskey · 2022 to 2026
$7.8M
Gilead Sciences (Gilead) Research ScholarsHHS | NIH | National Cancer Institute (NCI) 1DP2CA280623-01HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U01AI169385HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) UM1AI64565Pew Charitable Trusts (Pew) Research Scholars
6 · The paper itself

Abstract

Broadly neutralizing antibodies (bNAbs) show promise for HIV treatment and prevention, but are vulnerable to resistance evolution. Comprehensively understanding in vivo viral escape from individual bNAbs is necessary to design bNAb combinations that will provide durable responses. We characterize viral escape from two such bNAbs, 10-1074 and 3BNC117, using deep, longitudinal sequencing of full-length HIV envelope (

Indexed as

Antibodies, NeutralizingHIV-1HIV AntibodiesHIV InfectionsImmune EvasionMutationenv Gene Products, Human Immunodeficiency VirusEvolution, MolecularHumansAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesbNAbescapeevolutionHIVresistance

Identifiers

PMID41980093
PMCPMC13099683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.